Clinical Trial Update: Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a combination regimen of cisplatin, capecitabine, gemcitabine with either epirubicin or docetaxel in stage III or IV pancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• Epirubicin (epirubicin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED